Concepts (108)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cystic Fibrosis | 12 | 2014 | 264 | 0.870 |
Why?
|
| Pseudomonas Infections | 6 | 2013 | 156 | 0.450 |
Why?
|
| Pseudomonas aeruginosa | 5 | 2013 | 233 | 0.310 |
Why?
|
| Tobramycin | 3 | 2011 | 21 | 0.240 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 2 | 2014 | 50 | 0.150 |
Why?
|
| Respiratory Function Tests | 3 | 2012 | 318 | 0.140 |
Why?
|
| Aminophenols | 1 | 2014 | 12 | 0.130 |
Why?
|
| Ion Channel Gating | 1 | 2014 | 141 | 0.120 |
Why?
|
| Quinolones | 1 | 2014 | 160 | 0.120 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2013 | 202 | 0.100 |
Why?
|
| Ciprofloxacin | 1 | 2011 | 89 | 0.100 |
Why?
|
| Respiratory Syncytial Virus Infections | 2 | 2007 | 427 | 0.100 |
Why?
|
| Anti-Bacterial Agents | 3 | 2011 | 2992 | 0.100 |
Why?
|
| Cough | 1 | 2011 | 116 | 0.100 |
Why?
|
| Respiratory Tract Infections | 2 | 2007 | 437 | 0.090 |
Why?
|
| Anti-Infective Agents | 1 | 2011 | 446 | 0.080 |
Why?
|
| Plethysmography | 3 | 2011 | 31 | 0.080 |
Why?
|
| Metapneumovirus | 1 | 2007 | 58 | 0.070 |
Why?
|
| Paramyxoviridae Infections | 1 | 2007 | 86 | 0.070 |
Why?
|
| Maximal Expiratory Flow-Volume Curves | 1 | 2004 | 1 | 0.060 |
Why?
|
| Maximal Expiratory Flow Rate | 1 | 2004 | 2 | 0.060 |
Why?
|
| Respiratory Syncytial Virus, Human | 1 | 2007 | 211 | 0.060 |
Why?
|
| Clinical Trials as Topic | 2 | 2011 | 3719 | 0.060 |
Why?
|
| Child, Preschool | 9 | 2012 | 16273 | 0.060 |
Why?
|
| Genome, Bacterial | 1 | 2003 | 200 | 0.060 |
Why?
|
| Administration, Inhalation | 3 | 2011 | 285 | 0.050 |
Why?
|
| Carrier State | 1 | 2002 | 90 | 0.050 |
Why?
|
| Oscillometry | 2 | 2011 | 26 | 0.050 |
Why?
|
| Vaccines, Synthetic | 1 | 2003 | 355 | 0.050 |
Why?
|
| Spirometry | 2 | 2011 | 143 | 0.050 |
Why?
|
| Oligopeptides | 1 | 2003 | 429 | 0.050 |
Why?
|
| Forced Expiratory Volume | 2 | 2014 | 314 | 0.050 |
Why?
|
| Viral Vaccines | 1 | 2003 | 304 | 0.050 |
Why?
|
| Infant | 6 | 2012 | 13310 | 0.040 |
Why?
|
| Longitudinal Studies | 2 | 2011 | 1945 | 0.030 |
Why?
|
| Feasibility Studies | 2 | 2011 | 2292 | 0.030 |
Why?
|
| Mutation | 1 | 2014 | 15179 | 0.030 |
Why?
|
| Double-Blind Method | 2 | 2014 | 2588 | 0.030 |
Why?
|
| Prospective Studies | 4 | 2012 | 12873 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2014 | 460 | 0.030 |
Why?
|
| Molecular Typing | 1 | 2013 | 55 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2011 | 4971 | 0.030 |
Why?
|
| Male | 10 | 2014 | 123000 | 0.030 |
Why?
|
| Molecular Epidemiology | 1 | 2013 | 246 | 0.030 |
Why?
|
| Female | 10 | 2014 | 141928 | 0.020 |
Why?
|
| Infection Control | 1 | 2013 | 270 | 0.020 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2011 | 105 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2011 | 6009 | 0.020 |
Why?
|
| Child | 5 | 2014 | 29154 | 0.020 |
Why?
|
| Placebos | 1 | 2011 | 437 | 0.020 |
Why?
|
| Genotype | 2 | 2013 | 4109 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2013 | 1053 | 0.020 |
Why?
|
| Humans | 13 | 2014 | 261506 | 0.020 |
Why?
|
| Hospitals, Pediatric | 1 | 2013 | 773 | 0.020 |
Why?
|
| Solutions | 1 | 2007 | 104 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2011 | 1544 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2014 | 2203 | 0.020 |
Why?
|
| Nasopharynx | 1 | 2007 | 119 | 0.020 |
Why?
|
| Morbidity | 1 | 2007 | 397 | 0.020 |
Why?
|
| Functional Residual Capacity | 1 | 2004 | 15 | 0.020 |
Why?
|
| Pyocins | 1 | 2003 | 3 | 0.020 |
Why?
|
| Pigments, Biological | 1 | 2003 | 12 | 0.020 |
Why?
|
| Base Composition | 1 | 2003 | 92 | 0.010 |
Why?
|
| Pseudomonas Phages | 1 | 2003 | 10 | 0.010 |
Why?
|
| Databases as Topic | 1 | 2004 | 133 | 0.010 |
Why?
|
| Melanins | 1 | 2003 | 50 | 0.010 |
Why?
|
| Gene Transfer, Horizontal | 1 | 2003 | 57 | 0.010 |
Why?
|
| RNA, Transfer | 1 | 2003 | 77 | 0.010 |
Why?
|
| Audiometry | 1 | 2002 | 24 | 0.010 |
Why?
|
| Immunization Schedule | 1 | 2003 | 117 | 0.010 |
Why?
|
| Hearing Disorders | 1 | 2002 | 29 | 0.010 |
Why?
|
| Oropharynx | 1 | 2002 | 74 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2011 | 4988 | 0.010 |
Why?
|
| Incidence | 1 | 2013 | 5673 | 0.010 |
Why?
|
| Sputum | 1 | 2002 | 141 | 0.010 |
Why?
|
| Respiratory Syncytial Viruses | 1 | 2003 | 171 | 0.010 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2002 | 254 | 0.010 |
Why?
|
| Reference Values | 1 | 2004 | 1099 | 0.010 |
Why?
|
| Adaptation, Physiological | 1 | 2003 | 360 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2011 | 4314 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2011 | 6100 | 0.010 |
Why?
|
| DNA, Bacterial | 1 | 2003 | 558 | 0.010 |
Why?
|
| Seasons | 1 | 2003 | 340 | 0.010 |
Why?
|
| Safety | 1 | 2002 | 465 | 0.010 |
Why?
|
| Drug Monitoring | 1 | 2002 | 333 | 0.010 |
Why?
|
| Creatinine | 1 | 2002 | 531 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2004 | 1546 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2003 | 875 | 0.010 |
Why?
|
| Adolescent | 2 | 2014 | 31252 | 0.010 |
Why?
|
| Adjuvants, Immunologic | 1 | 2003 | 657 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2011 | 9244 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2003 | 1555 | 0.010 |
Why?
|
| Hospitalization | 1 | 2007 | 2083 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2003 | 2508 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2012 | 14889 | 0.010 |
Why?
|
| Kidney Diseases | 1 | 2002 | 691 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2002 | 3472 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2011 | 32848 | 0.010 |
Why?
|
| Young Adult | 1 | 2014 | 21445 | 0.010 |
Why?
|
| Risk Factors | 1 | 2013 | 17523 | 0.010 |
Why?
|
| Patient Selection | 1 | 2003 | 2055 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2003 | 2086 | 0.010 |
Why?
|
| United States | 1 | 2011 | 15433 | 0.010 |
Why?
|
| Time Factors | 1 | 2007 | 12926 | 0.010 |
Why?
|
| Age Factors | 1 | 2002 | 5377 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2002 | 4320 | 0.010 |
Why?
|
| Adult | 1 | 2014 | 77950 | 0.000 |
Why?
|
| Middle Aged | 1 | 2014 | 86204 | 0.000 |
Why?
|